Positioning with Commitment
Amicure focuses on the R&D, regulatory registration, and industrialization of therapeutics and medical devices for companion animals. Our core advantages are “integrated diagnosis and treatment” and “personalized therapy.”
We provide end-to-end support for partners—from research to clinical, and from registration to market access.
We help bring safe, effective, and convenient pet treatment solutions to market faster.
Collaboration Scope and Models
Joint R&D: Centered on small molecules, antibody therapeutics, and liposomal nanotechnology—from target validation, formulation and process optimization, to pilot-scale manufacturing—setting verifiable technical milestones.
Clinical Translation: Design and conduct companion animal clinical studies, establish real-world evidence (RWE), and strengthen proof of efficacy and safety.
Regulatory and Compliance: Plan differentiated regulatory pathways for the U.S. and China, prepare submission dossiers, and ensure closed-loop communication and feedback management with review authorities.
Integrated Diagnosis and Personalized Therapy: Combine clinical services with drug development; define hospital-executable care pathways based on indications and individual variability.
Market Access and Co-Promotion: Academic education, KOL networks, channel expansion, and joint brand activities—moving from pilots to scaled adoption.
Capital Collaboration: Provide due diligence frameworks, valuation and term guidance, investor matching and negotiation support—aligning funding pace with execution milestones.
Partners We Serve
Pharmaceuticals & Medical Device Companies
Co-develop new formulations and companion diagnostics, complete the pet product portfolio, and shorten time-to-market.
Veterinary Medical Institutions
Introduce new therapies and care pathways to improve outcomes and satisfaction, forming replicable hospital-side solutions.
Accelerators and Incubators
Offer R&D resources, clinical translation support, and regulatory guidance to improve project success rates.
Investment Institutions
Conduct pipeline due diligence and value assessment, define milestone plans, and assist with registration and industrialization.
Support of Amicure Venture
Phase 1
Preparation
- Objective Definition: Clarify indications, technology readiness level (TRL), and clinical and commercial goals.
- Simulated Due Diligence: Review technical white papers, CMC overviews, and clinical/regulatory pathways from an investor/regulator perspective.
- Data Room Readiness: Build professional external materials to improve cross-team evaluation and decision efficiency.
Phase 2
Matching and Engagement
- Precise Matching: Align partners or investors by technology focus, market geography, and resource endowment.
- Deep Communication: Arrange technical and business meetings to calibrate milestones, deliverables, and risk buffers.
- Plan Finalization: Jointly optimize study design, manufacturing, and regulatory cadence to form executable project plans.
Phase 3
Terms and Execution
- erm Negotiation: Align on IP ownership/licensing, data and ethics, budget, and timeline.
- Project Delivery: Parallel registrations in two geographies; integrated execution across R&D–clinical–manufacturing; transparent milestone management.
- Review and Scale-Up: Stage evaluations and performance reviews; pathways from pilots to regional/national expansion.
Contact Us
The AMICURE team is ready to answer all questions regarding venture support and partnership. Simply complete the form and we will contact you shortly.